{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"What happened to HEMGENIX!? An update on gene therapy.","description":"CSL Behring just announced a global \u201cstockout\u201d of Hemgenix\u2014what\u2019s happening, and what does it mean for patients? On this episode of BloodStream Podcast, we break down the news, launch our mini-series on plasma donation, and hear from Thomas Savage in our I\u2019m Fine segment, sharing the highs, the lows, and the reality of living with a severe bleeding disorder.&amp;nbsp; Pain, perseverance, and the lessons learned along the way give a rare, unfiltered glimpse into life behind the headlines\u2014reminding us all that every treatment, every donation, and every day matters. Show Notes: I\u2019m Fine is presented by @SanofiUS&amp;nbsp; #bloodstreammedia #raredisease #bleedingdisorders #podcast #chronicdisease #hemophiliacommunity #advocacy &amp;nbsp; Presenting Sponsor: Takeda, visit bleedingdisorders.com to learn more.   Subscribe: The BloodStream Podcast &amp;nbsp; Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook&amp;nbsp; BloodStream on X\/Twitter&amp;nbsp; BloodStream on Instagram BloodStream on LinkedIn BloodStream on TikTok &amp;nbsp; ","author_name":"BloodStream","author_url":"http:\/\/BloodStreamPod.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40774915\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/200561000"}